Answers are grounded in this paper and cite their sources.
Neuropeptide Y and its receptors play a role in cardiovascular regulation, and targeting these receptors may offer therapeutic potential for primary hypertension.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jennifer C. Gander (2014) conducted a review in Primary hypertension. Neuropeptide Y (NPY) receptor agonists and antagonists was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: